Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study
Journal of Atherosclerosis and Thrombosis · 01.07.2026 · 33 (7) · 968-978
DOI: 10.5551/jat.66030 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.07.2026. Verfasst von Takao Sato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, IUHW Narita hospital. Hauptthemen laut MEDLINE: Benzoxazoles, Biomarkers, Butyrates, Dyslipidemias. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, IUHW Narita hospital.
- Department of Cardiology, IUHW Atami hospital.
Zitieren
APA
Sato, T., Miyamoto, T., Fukuoka, R., Sugimoto, K., Tanimoto, Y., Nakayama, T., Tanimoto, K., Sugimura, K., Fujimoto, Y., Kiyooka, T., & Kawamura, A. (2026). Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study. Journal of Atherosclerosis and Thrombosis, 33(7), 968-978. https://doi.org/10.5551/jat.66030
Vancouver
Sato T, Miyamoto T, Fukuoka R, Sugimoto K, Tanimoto Y, Nakayama T, et al. Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study. Journal of Atherosclerosis and Thrombosis. 2026;33(7):968-978. doi:10.5551/jat.66030
BibTeX
@article{Sato2026,
author = {Sato, Takao and Miyamoto, Toshihiro and Fukuoka, Ryoma and Sugimoto, Kazumasa and Tanimoto, Yoko and Nakayama, Takashi and Tanimoto, Kojiro and Sugimura, Koichiro and Fujimoto, Yoshihide and Kiyooka, Takahiko and Kawamura, Akio},
title = {Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
volume = {33},
number = {7},
pages = {968--978},
doi = {10.5551/jat.66030}
}
EUVIMED